Given what we know, we can confirm that the "balance of nature" refers to a scientific theory about ecological homeostasis.
<h3>What does ecological homeostasis mean?</h3>
- This refers to the idea of a perfect balance in an ecosystem.
- It is the theory that all aspects of an ecosystem are and will remain balanced even if there are small changes.
- This implies that any minor change in an ecosystem will be corrected.
- This will happen through natural regulation mechanisms such as positive or negative feedback.
Therefore, we can confirm that the "balance of nature" is the scientific theory that all things in an ecosystem will remain balanced, meaning that if there is a small change, it will be corrected through some form of natural regulatory mechanism.
To learn more about ecosystems visit:
brainly.com/question/1673533?referrer=searchResults
This was answered before but here is the simplist answer of two differences
Mitosis has 48 chromosomes which has the diploid cells ( Time when both parents genetics chromosomes info come together.
Meiosis has 24 chromosomes which has the haploid cells ( Involve cell division and gametes come into play.
Infectious diseases are caused by microscopic germs (such as bacteria or viruses) that get into the body and cause problems. Some — but not all — infectious diseases spread directly from one person to another. Infectious diseases that spread from person to person are said to be contagious.
Answer:
Phase III
Explanation:
The given condition fall in the trial phase (Phase III) of cinical study which aims to:
- Determine drug's effectiveness (primary goal)
- Determine long-term drug safety
- Confirm findings
In Phase III, randomised, double-blind, placebo-controlled, parallel group study is majorly to evaluate the efficacy and safety of placebo in episodic migraine prevention in children (6 to < 12 years of age) and adolescents (12 to < 18 years of age).
The trial consists of four phases: screening; double-blind therapy period for 24 weeks in which placebo or Erenumab is given to subject as dose 1, dose 2 or dose 3 (based on the participant's body weight) once a month via subcutaneous injection; optional dose level blinded extension phase (40 weeks) which involves subjects recieve dose1, 2 and 3 of placebo, and at last it follows a safety follow-up phase for 12 weeks (after 16 weeks of the last dose of investigational drug).
Hence, the clinical phase is phase III.
Gene: polypeptide are equivalent units of info